Recombinant UPF0319 protein VP1009 (VP1009) is a protein variant derived from the UPF0319 family, which is often associated with proteins of unknown function. The recombinant form of this protein is engineered for expression and purification in various host systems, such as bacteria (e.g., Escherichia coli), yeast, insect cells, and mammalian cells. This versatility allows researchers to optimize the protein's production based on specific requirements, including yield, post-translational modifications, and biological activity.
The expression of recombinant UPF0319 protein VP1009 can be achieved through several host systems, each offering distinct advantages:
| Host System | Advantages | Disadvantages |
|---|---|---|
| E. coli | High yield, cost-effective, rapid production | Limited post-translational modifications |
| Yeast | Similar to E. coli, with some additional modifications | May not fully replicate mammalian modifications |
| Insect Cells with Baculovirus | Provides complex post-translational modifications | More expensive and complex setup |
| Mammalian Cells | Offers comprehensive post-translational modifications | High cost, complex to work with |
Future research on recombinant UPF0319 protein VP1009 should focus on elucidating its biological functions and exploring potential therapeutic or biotechnological applications. This may involve structural studies to understand its interactions with other cellular components and functional assays to determine its role in cellular processes.
Lifeome. UPF0319 protein VP10 - Lifeome. [Accessed 2025]
Lifeome. UPF0319 protein VPA1 - Lifeome. [Accessed 2025]
UPF0319 protein belongs to a family of uncharacterized proteins with potential functional significance in cellular processes. For recombinant expression of UPF0319 protein VP1, multiple host systems can be utilized, with E. coli and yeast offering the highest yields and most efficient production timelines. These prokaryotic and lower eukaryotic systems are particularly advantageous when large quantities of protein are required for structural or preliminary functional studies .
For applications requiring post-translational modifications, insect cells with baculovirus expression systems or mammalian cell expression platforms are recommended, as these systems can provide the necessary cellular machinery for correct protein folding and functional activity retention . The choice between expression systems should be guided by the specific research requirements, including protein purity needs, functional activity requirements, and experimental timeline constraints.
Expression yields of recombinant UPF0319 protein VP1 vary significantly across host systems:
While both proteins share "UPF" in their nomenclature, they represent distinct protein families with different functions and characteristics. UPF0319 is an uncharacterized protein family (hence the UPF designation), whereas Upf1p is a well-characterized 971-amino acid protein essential for nonsense-mediated mRNA decay (NMD) .
Upf1p specifically interacts with nuclear pore proteins Nup100p and Nup116p, facilitating its association with newly synthesized mRNA as it is transported from the nucleus to the cytoplasm . This interaction is crucial for the NMD pathway that degrades mRNAs containing premature termination codons. In contrast, the specific functional interactions and physiological roles of UPF0319 proteins are still being elucidated, making them an active area of investigation in current research.
When optimizing UPF0319 protein VP1 expression in E. coli, researchers should consider implementing the following evidence-based strategies:
Codon optimization: Adjust the coding sequence to reflect E. coli codon usage preferences, which can significantly enhance translation efficiency.
Expression vector selection: Test multiple vector systems with different promoters (T7, tac, etc.) to identify optimal transcriptional control for your specific protein construct.
Host strain selection: Compare expression levels in specialized strains such as BL21(DE3), Rosetta, or SHuffle, which are engineered to address specific protein expression challenges.
Induction conditions optimization: Systematically vary IPTG concentration (0.1-1.0 mM), induction temperature (16-37°C), and induction duration (4-24 hours) to identify conditions that maximize soluble protein yield.
Culture media formulation: Compare standard LB with enriched media such as TB or auto-induction media to enhance biomass and protein production.
These methodological approaches should be applied systematically, with careful documentation of expression results under each condition to determine the optimal combination for your specific UPF0319 protein VP1 construct .
A robust purification protocol for recombinant UPF0319 protein VP1 typically involves sequential chromatographic techniques:
Initial capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA or Co-NTA resins is highly effective for His-tagged UPF0319 protein constructs, allowing for specific binding under native or denaturing conditions.
Intermediate purification: Ion exchange chromatography can separate the target protein from contaminants with different charge properties. The selection between cation or anion exchange depends on the isoelectric point of your specific UPF0319 construct.
Polishing step: Size exclusion chromatography (SEC) provides final purification and allows assessment of protein homogeneity, aggregation state, and oligomerization.
Quality control assessment: Analytical techniques including SDS-PAGE, Western blotting, and mass spectrometry should be employed to verify protein identity, purity, and integrity.
The specific buffer conditions, salt concentrations, and pH values should be optimized empirically for each step to maximize yield while maintaining protein stability and activity .
When encountering expression challenges with UPF0319 protein VP1, implement this systematic troubleshooting approach:
For low expression issues:
Verify expression vector sequence integrity
Evaluate mRNA stability using RT-PCR
Test different E. coli strains (BL21, Rosetta for rare codons)
Modify induction parameters (lower temperature, reduced IPTG)
Consider auto-induction media to avoid toxicity issues
For protein insolubility:
Reduce expression rate (lower temperature, weaker promoter)
Co-express with molecular chaperones (GroEL/ES, DnaK)
Test fusion partners (SUMO, MBP, Thioredoxin) known to enhance solubility
Optimize lysis conditions and buffer components
Evaluate refolding protocols from inclusion bodies if necessary
Implementing a design of experiments (DOE) approach can efficiently identify optimal conditions by testing multiple variables simultaneously rather than varying one factor at a time .
A comprehensive structural characterization of UPF0319 protein VP1 should incorporate multiple complementary techniques:
Secondary structure analysis:
Circular dichroism (CD) spectroscopy to determine α-helix, β-sheet, and random coil content
Fourier-transform infrared spectroscopy (FTIR) as a complementary method for secondary structure determination
Tertiary structure characterization:
X-ray crystallography for high-resolution structural determination (requires successful crystallization)
Nuclear magnetic resonance (NMR) spectroscopy for solution-state structural analysis (more suitable for smaller domains)
Cryo-electron microscopy for larger assemblies or complexes
Stability and conformational assessment:
Differential scanning calorimetry (DSC) to measure thermal stability
Intrinsic fluorescence spectroscopy to monitor tertiary structure changes
Limited proteolysis combined with mass spectrometry to identify domain boundaries and flexible regions
Quaternary structure analysis:
Size exclusion chromatography with multi-angle light scattering (SEC-MALS) for accurate molecular weight determination
Analytical ultracentrifugation to characterize oligomerization states and heterogeneity
These methodologies provide complementary information about protein structure and should be selected based on available instrumentation and specific research questions .
Since UPF0319 proteins are uncharacterized, functional assessment requires multiple approaches:
Binding partner identification:
Pull-down assays using the recombinant protein as bait
Yeast two-hybrid screening to identify potential protein-protein interactions
Co-immunoprecipitation studies with candidate interacting partners
Surface plasmon resonance (SPR) or bio-layer interferometry (BLI) for quantitative binding kinetics
Functional domain mapping:
Creation of truncation or deletion mutants to identify functional regions
Site-directed mutagenesis of conserved residues to assess their importance
Domain swapping experiments with related proteins
Cellular localization studies:
Immunofluorescence microscopy with tagged recombinant protein
Subcellular fractionation followed by Western blotting
Live-cell imaging with fluorescently labeled protein
Enzymatic activity screening:
General assays for nucleic acid binding, ATPase activity, or other common biochemical functions
Substrate specificity determination if enzymatic activity is identified
These approaches should be conducted systematically to build a comprehensive understanding of the protein's function, starting with broader screening methods before proceeding to more targeted analyses .
Despite limited sequence homology, structural biology approaches can potentially reveal functional relationships between UPF0319 and better-characterized proteins like Upf1p:
Structural homology modeling:
Generate computational models of UPF0319 protein using available protein structure prediction tools
Compare predicted structural features with known Upf1p domains
Identify potential conserved structural motifs despite sequence divergence
Structural alignment analysis:
Utilize tools like DALI or TM-align to compare experimental or predicted structures
Identify potential functional sites based on structural conservation
Map evolutionarily conserved residues onto structures to identify functional hotspots
Protein-protein interaction surface mapping:
Domain function transfer experiments:
Create chimeric proteins swapping domains between UPF0319 and Upf1p
Assess functional complementation in appropriate assay systems
Identify minimal functional units through progressive domain exchange
This integrative approach combines computational prediction with experimental validation to systematically explore potential functional relationships between these protein families .
For structural biology applications, specialized expression strategies are essential:
Development of sensitive and specific proteomic assays for UPF0319 protein VP1 requires:
Peptide selection strategy:
Identify proteotypic peptides unique to UPF0319 protein VP1
Select peptides with favorable ionization properties for mass spectrometry
Avoid regions prone to post-translational modifications or processing
Synthesize stable isotope-labeled standards of selected peptides
Multiple reaction monitoring (MRM) assay development:
Optimize collision energies for each target peptide
Determine retention time windows for scheduled MRM
Establish limits of detection and quantification
Validate assay specificity against complex matrix backgrounds
Sample preparation optimization:
Develop efficient extraction protocols for different sample types
Establish procedures to minimize protein degradation
Implement fractionation strategies for low-abundance targets
Optimize digestion conditions for complete and reproducible processing
Data analysis and validation approach:
Implement appropriate normalization strategies
Establish technical and biological variation parameters
Develop standard curves using recombinant protein standards
Validate results with orthogonal methods (Western blotting, ELISA)
This methodological framework enables absolute quantification of UPF0319 protein VP1 across different experimental conditions and sample types, facilitating functional studies in complex biological systems .
Despite sharing "VP1" in their nomenclature, UPF0319 protein VP1 and viral capsid VP1 proteins (such as those in Porcine bocavirus) represent distinct protein families with fundamentally different functions:
Structural and functional differences:
Evolutionary relationship:
Viral VP1 proteins evolved specifically for viral structural requirements
UPF0319 proteins likely evolved within cellular contexts for non-viral functions
Any naming similarities are coincidental rather than indicative of functional relationships
Research methodologies:
Viral VP1 proteins are often studied in the context of viral assembly, immunogenicity, and host-cell interactions
UPF0319 proteins require unbiased functional genomics approaches to elucidate their roles
Different experimental systems are typically employed for these distinct protein families
Understanding these fundamental differences is crucial when reviewing literature, as search results may include information about both protein families despite their distinct biological contexts and functions .
Comparative genomics approaches provide valuable insights into UPF0319 protein evolution and function:
Phylogenetic distribution analysis:
Map the presence/absence of UPF0319 across diverse species
Identify patterns of co-evolution with other gene families
Determine if horizontal gene transfer events have occurred
Sequence conservation mapping:
Identify highly conserved motifs across diverse species
Map conservation onto structural models to identify functional sites
Compare conservation patterns with related protein families
Genomic context analysis:
Examine operon structures in prokaryotes containing UPF0319 genes
Analyze promoter elements and regulatory sequences
Identify consistently co-regulated genes across species
Methodological framework for functional prediction:
Implement gene neighborhood analysis
Utilize protein-protein interaction network integration
Apply gene expression correlation analysis
Perform phenotypic profiling of knockout/knockdown organisms
These approaches can generate testable hypotheses about UPF0319 protein function based on evolutionary relationships and genomic context, guiding experimental design for functional characterization studies .
While UPF0319 proteins and viral VP1 proteins serve distinct biological functions, the methodological approaches used for developing the VP1-based ELISA for Porcine bocavirus can inform similar applications for UPF0319 proteins:
Peptide epitope identification strategy:
Analyze UPF0319 protein sequences for regions with high antigenicity
Design synthetic peptides representing conserved regions with predicted surface exposure
Validate peptide immunogenicity in appropriate animal models
Assay development methodology:
Optimize coating conditions for recombinant protein or synthetic peptides
Establish appropriate blocking conditions to minimize background
Determine optimal sample dilutions and incubation parameters
Validate specificity against related protein families
Performance optimization approach:
Implement checkerboard titration to determine optimal reagent concentrations
Establish reproducibility parameters through intra- and inter-assay variation analysis
Determine sensitivity limits using purified recombinant protein standards
Validate against diverse sample matrices
Limitations and considerations:
Recognize that biological relevance depends on establishing UPF0319 protein connection to disease or physiological states
Address potential cross-reactivity with structural homologs
Establish appropriate reference standards for quantification
These methodological frameworks can be applied to develop sensitive and specific assays for UPF0319 proteins once their biological significance is better established through basic research .
CRISPR-Cas9 technology offers powerful approaches for UPF0319 functional characterization:
Knockout strategy design:
Generate complete gene deletions to assess loss-of-function phenotypes
Create conditional knockout systems for essential genes
Implement tissue-specific or inducible knockout approaches in complex organisms
Design appropriate controls including rescue experiments with recombinant protein
Protein tagging methodology:
Create endogenous C- or N-terminal tags for localization studies
Implement split-GFP or HaloTag systems for dynamic protein interaction studies
Design epitope tags for chromatin immunoprecipitation if DNA-binding functions are suspected
Validate tag impact on protein function through complementation assays
Domain function analysis:
Generate precise deletions of predicted functional domains
Create point mutations in conserved residues
Implement base editing for specific amino acid substitutions
Design domain swaps to test functional hypotheses
High-throughput screening approaches:
Develop CRISPR activation (CRISPRa) or interference (CRISPRi) libraries
Implement pooled screenings with phenotypic selection
Design synthetic genetic interaction screens
Establish appropriate readout systems for phenotypic assessment
These genetic engineering approaches provide powerful tools to systematically investigate UPF0319 protein function in relevant cellular contexts, complementing biochemical studies with recombinant proteins .